Leo Drug Patent Portfolio
Leo owns 8 orange book drugs protected by 43 US patents with Anzupgo having the least patent protection, holding only 1 patent. And Picato with maximum patent protection, holding 16 patents. Given below is the list of Leo's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9789078 | Method of topically treating actinic keratosis with ingenol mebutate cycle therapy | 15 May, 2033 | Active |
| US10130640 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Dec, 2031 | Active |
| US9119781 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Dec, 2031 | Active |
| US8609647 | 19 Sep, 2031 | Active | |
| US10130640 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10617698 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10660908 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10682364 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10688108 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10716799 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US9119781 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US9566286 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US9211259 | Antibiotic kit and composition and uses thereof | 28 Feb, 2029 | Active |
| US9265725 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof | 08 Dec, 2027 | Active |
| US10117812 | Foamable composition combining a polar solvent and a hydrophobic carrier | 18 Oct, 2027 | Active |
| US7700076 | Penetrating pharmaceutical foam | 18 Sep, 2027 | Active |
| US8278292 | Therapeutic compositions | 06 Jul, 2027 | Active |
| US8372827 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US8372828 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US8377919 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US8536163 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US8716271 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US8735375 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US9820959 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US9833428 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US9833429 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US9861603 | Therapeutic compositions | 18 Dec, 2026 | Active |
| US8435498 | Penetrating pharmaceutical foam | 01 Mar, 2024 | Expired |
| US10322085 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof | 24 Oct, 2023 | Expired |
| US8722021 | Foamable carriers | 24 Oct, 2023 | Expired |
| US8900554 | Foamable composition and uses thereof | 24 Oct, 2023 | Expired |
| US6387383 | Topical low-viscosity gel composition | 03 Aug, 2020 | Expired |
| US6753013 | Pharmaceutical composition | 27 Jan, 2020 | Expired |
| US6787529 | Topical composition | 27 Jan, 2020 | Expired |
| US6730288 | Mousse composition | 08 Sep, 2019 | Expired |
| US6844013 | Methods of stimulating the immune system | 13 Dec, 2018 | Expired |
| US6534070 | Composition with azelaic acid | 18 Nov, 2018 | Expired |
| US6432452 | Anti-cancer compounds | 19 Aug, 2018 | Expired |
| US6787161 | Anti-cancer compounds | 19 Aug, 2018 | Expired |
| US7410656 | Anti-cancer compounds | 19 Aug, 2018 | Expired |
| US5763426 | Crystalline form of a vitamin D analogue | 09 Jun, 2015 | Expired |
| USRE39706 | Crystalline form of a vitamin D analogue | 09 Jun, 2015 | Expired |
| US5665727 | Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them | 09 Sep, 2014 | Expired |
Latest Legal Activities on Leo's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Leo.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 01 Jul, 2024 | US9566286 |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US8278292 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US8536163 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US9789078 |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US8377919 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US8716271 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US9833429 |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US8735375 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US9833428 |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US9861603 |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US8372827 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US9820959 |
|
Correspondence Address Change
Critical
| 26 Jun, 2024 | US8372828 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 20 May, 2024 | US8278292 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 29 Nov, 2023 | US10716799 |
Leo Drug Patents' Oppositions Filed in EPO
Leo drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Nov 11, 2014, by Sandoz Ag. This opposition was filed on patent number EP06820561A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP11726055A | Sep, 2015 | Pentafarma Sociedade Técnico-Medicinal S.A. | Opposition rejected |
| EP03772600A | Sep, 2015 | Henkel AG & Co. KGaA | Patent maintained as amended |
| EP03772600A | Dec, 2014 | Guderma GmbH | Patent maintained as amended |
| EP06820561A | Nov, 2014 | Actavis PTC ehf | Revoked |
| EP06820561A | Nov, 2014 | Galenicum Health S.L. | Revoked |
| EP06820561A | Nov, 2014 | Sandoz AG | Revoked |
Leo's Family Patents
Clinical Trials
Recent Clinical Trials by Leo:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Investigation of Flare and Remission in Subjects With Atopic Dermatitis | LEO Pharma | NA |
WITHDRAWN
(Jul, 2019)
| PHASE4 |
Leo Drug List
Given below is the complete list of Leo's drugs and the patents protecting them.
1. Anzupgo
Anzupgo is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8609647 |
19 Sep, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Anzupgo's drug page
2. Desonate
Desonate is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6387383 | Topical low-viscosity gel composition |
03 Aug, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Desonate's drug page
3. Dovonex
Dovonex is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5763426 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(10 years ago)
| Expired |
| USRE39706 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dovonex's drug page
4. Enstilar
Enstilar is protected by 11 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10130640
(Pediatric)
| Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Dec, 2031
(5 years from now)
| Active |
| US9119781
(Pediatric)
| Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Dec, 2031
(5 years from now)
| Active |
| US10130640 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US10617698 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US10660908 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US10682364 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US10688108 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US10716799 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US9119781 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US9566286 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(5 years from now)
| Active |
| US6753013 | Pharmaceutical composition |
27 Jan, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Enstilar's drug page
5. Finacea
Finacea is protected by 10 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9211259 | Antibiotic kit and composition and uses thereof |
28 Feb, 2029
(3 years from now)
| Active |
| US9265725 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
08 Dec, 2027
(1 year, 10 months from now)
| Active |
| US10117812 | Foamable composition combining a polar solvent and a hydrophobic carrier |
18 Oct, 2027
(1 year, 9 months from now)
| Active |
| US7700076 | Penetrating pharmaceutical foam |
18 Sep, 2027
(1 year, 8 months from now)
| Active |
| US8435498 | Penetrating pharmaceutical foam |
01 Mar, 2024
(1 year, 10 months ago)
| Expired |
| US10322085 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
24 Oct, 2023
(2 years ago)
| Expired |
| US8722021 | Foamable carriers |
24 Oct, 2023
(2 years ago)
| Expired |
| US8900554 | Foamable composition and uses thereof |
24 Oct, 2023
(2 years ago)
| Expired |
| US6730288 | Mousse composition |
08 Sep, 2019
(6 years ago)
| Expired |
| US6534070 | Composition with azelaic acid |
18 Nov, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Finacea's drug page
Explore Our Curated Drug Screens
6. Picato
Picato is protected by 16 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9789078 | Method of topically treating actinic keratosis with ingenol mebutate cycle therapy |
15 May, 2033
(7 years from now)
| Active |
| US8278292 | Therapeutic compositions |
06 Jul, 2027
(1 year, 5 months from now)
| Active |
| US8372827 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US8372828 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US8377919 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US8536163 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US8716271 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US8735375 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US9820959 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US9833428 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US9833429 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US9861603 | Therapeutic compositions |
18 Dec, 2026
(11 months from now)
| Active |
| US6844013 | Methods of stimulating the immune system |
13 Dec, 2018
(7 years ago)
| Expired |
| US6432452 | Anti-cancer compounds |
19 Aug, 2018
(7 years ago)
| Expired |
| US6787161 | Anti-cancer compounds |
19 Aug, 2018
(7 years ago)
| Expired |
| US7410656 | Anti-cancer compounds |
19 Aug, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Picato's drug page
7. Protopic
Protopic is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5665727 | Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them |
09 Sep, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Protopic's drug page
8. Taclonex
Taclonex is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6753013 | Pharmaceutical composition |
27 Jan, 2020
(5 years ago)
| Expired |
| US6787529 | Topical composition |
27 Jan, 2020
(5 years ago)
| Expired |
| US5763426 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(10 years ago)
| Expired |
| USRE39706 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Taclonex's drug page